Navigation Links
New Study Confirms VASER Lipo Results Are Superior to Standard Liposuction
Date:10/24/2009

SEATTLE, Oct. 24 /PRNewswire/ -- At the 78th Annual American Society of Plastic Surgeons Annual (ASPS) Meeting, Dr. Paul Vanek presented a study that confirms that VASER-Assisted Lipoplasty (VAL) delivers superior results over traditional Suction-Assisted Lipoplasty (SAL) in skin retraction and blood loss.

In a study called "A Multi-Center, Prospective, Randomized, Single-Blind, Controlled Clinical Trial Comparing VASER-Assisted Lipoplasty and Suction-Assisted Lipoplasty" results showed that the VASER Lipo treatment demonstrated 53% improvement in skin retraction per mL of aspirate removed relative to the standard SAL method, and a 26% reduction in blood loss. This is the first study to demonstrate statistically significant and clinically relevant improvements in a new lipoplasty technology relative to SAL. This prospective study used a contra-lateral (side-by-side) study design to evaluate post-operative differences between the two techniques over a six-month time period.

"Physicians have been reporting skin tightening benefits and reduced blood loss with the VASER Lipo System since the technology was released in 2002," said Dan Goldberger, CEO of Sound Surgical Technologies LLC. "This study now provides empirical evidence of yet another advantage of using VASER ultrasonic energy in all body contouring procedures."

The study involved twenty female patients between the ages of 20 and 48 who received contra-lateral treatment with traditional liposuction and VASER Lipo in one or more anatomical regions that included the upper arms, upper back, flanks, outer thighs, and inner thighs for a total of 33 regions. Patients were blinded to the technology that was used on them and aspirate was kept separate and analyzed for blood content. Skin retraction was measured using changes in UV tattoos placed prior to surgery.

The study was funded by Sound Surgical Technologies LLC, and the authors received no stipends to participate in the clinical trial. Neither author has a financial interest in any of the products or devices used in the study.

About VASER Lipo - The VASER Lipo System was designed to provide physicians with a versatile tool to treat all areas of the body, from small procedures in the face and neck, to large volume treatments in the abdomen and back. VASER ultrasonic energy is able to selectively liquefy fat while preserving important tissue structures vital to natural skin tightening. By preserving nerves, blood vessels and collagen, physicians report also experience minimal to no pain and bruising postoperatively allowing for a fast return to normal activities.

About Sound Surgical - Founded in 1998, Sound Surgical Technologies placed its first VASER Lipo System on the market in March 2001. More than 100,000 procedures have been performed worldwide using the VASER System. An alternative to traditional tumescent liposuction, the VASER - Vibration Amplification of Sound Energy at Resonance - Lipo System uses an advanced ultrasonic fat removal technology that has become a trusted method in a society saturated with fad procedures. Demanded by physicians and patients alike, the results are smooth and consistent with fast patient recovery. The VASER Lipo System is FDA cleared for body contouring.

Readers interested in learning more about VASER Lipo should visit www.VASER.com.

SOURCE Sound Surgical Technologies


'/>"/>
SOURCE Sound Surgical Technologies
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Biomoda Enters Final Stage of Patient Testing for Phase II Lung Cancer Clinical Study
2. Delcath Systems, Inc. Completes Phase III Study Enrollment
3. AlphaDetail Tracking Study Enhancements: The Advantage of Integration and Speed
4. Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Societys Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)
5. Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico
6. comScore Study Finds the Internet a Key Component in Consumer Research on Prescriptions and Health Conditions
7. Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences
8. CVS Caremark Undertakes Multi-Year Study to Improve Patient Medication Adherence
9. ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities
10. DATATRAK Signs 6 Year Study with New Device Client
11. Study Suggests that NGAL Identifies Acute Kidney Injury Early in ICU Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
Breaking Medicine Technology:
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):